Please visit our MS learning channel on YouTube, which provides hundreds of MS related topics from many of our video recorded education programs and archived here: -- Be empowered with MS views and news. Opt-in with us:

~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Friday, March 31, 2017

Ocrelizumab and Risk for Infections


Published on Feb 25, 2017
Dr. Daniel Kantor talks with Dr. Kottil Rammohan, Professor of Neurology at the University of Miami School of Medicine about Ocrelizumab and the risk for infections.

 Click above. Listen to Learn

Click here to receive MS news via e-mail
MS Views and News is MAKING an IMPACT on those affected by Multiple Sclerosis

1 comment:

Joan Quilter said...

They didn't, really, discuss the risks of this drug. I didn't hear them say the word "Cancer". I think that Big Pharma has a hand in this. $65,000 a treatment is a bit much to risk cancer.